Connect Biopharma Holdings Ltd (CNTB)
- Sector
- Healthcare
- Industry
- Biotechnology
- Last price
- $0.58
- As of
Kresmion compiles this page from CNTB's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Connect Biopharma Holdings Ltd (CNTB): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q3 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-11-16.
See the full CNTB dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for CNTB on one page. Preview it with sample data, then open it live with a free account.
Preview the CNTB dossierActive events for CNTB
- mediumEarnings above estimates
Q2-2026: Beat consensus by 16.0%, EPS $-0.27 vs $-0.3213 estimate
- high13F: large reduction
MILLENNIUM MANAGEMENT LLC cut 91% of CNTB (2026Q2)
- high13F: large increase
TWO SIGMA INVESTMENTS, LP added +320% to CNTB (2026Q2)
- mediumEarnings below estimates
Q4-2025: Missed consensus by 29.8% - EPS $-0.27007 vs $-0.208 estimate
- mediumEarnings below estimates
Q1-2026: Missed consensus by 50.2% - EPS $-0.33998 vs $-0.2264 estimate
FREE, NO ACCOUNT
Every event on CNTB, as it fires
You are seeing 5 of 10 events recorded on CNTB since 2026-05-29.
The five above landed across 3 days. The other 5 were recorded on 2 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
CNTB positions held by the managers we follow (2026Q3)
What the managers we follow bought and sold in Q2 2026
| Manager / security | Market value | % of reported value |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC FundCUSIP G23549101 · 2026Q3 | $70K | 0.00% |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. The share of reported value is each position's value over the sum of the values that manager reported for the quarter; option lines are not in that sum, as on each fund page. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, CNTB
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
Going concern statement
CNTB's 10-Q filed Nov 16, 2026 states:
These conditions raise substantial doubt about the Company's ability to continue as a going concern.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on CNTB
CNTB against its peers
CNTB's operating margin of -90740.6% ranks in the 6th percentile of 8 Biotechnology sub-industry peers, fiscal periods ending between 2025-04-30 and 2026-06-30.
| Metric | CNTB | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 64000 USD | 500000 USD | 25 | 9 |
| Operating margin | -90740.6% | -7038.9% | 6 | 8 |
| Net margin | -86687.5% | -5668.6% | 5 | 9 |
| Return on equity | -132.2% | -109.5% | 36 | 20 |
| 1 year | -79.6% | -56.3% | 19 | 23 |
Peers (24): ELTX, IMA, GRDX, EXOZ, ONCY, ATHE, GANX, ATNM, MREO, SGMOQ, TIL, CRBU, GRCE, OSTX, GNTA, LONA, HYPD, BMEA, ANVS, DWTX, HYFT, HOWL, IBIO, ALDX. Left out: TELO (no annual filing). Fiscal periods ending between 2025-04-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (CNTB: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Cite this data
Kresmion counts the managers it follows that reported a non-option position in CNTB on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on CNTB in the last 180 days.
Upstream: SEC EDGAR filings for CNTB
Kresmion, "Connect Biopharma Holdings Ltd (CNTB) institutional holdings and SEC filings", data as of 2026-11-16, https://kresmion.com/research/CNTB. Upstream data: SEC EDGAR filings for CNTB.
Link to this data (HTML):
<a href="https://kresmion.com/research/CNTB">Connect Biopharma Holdings Ltd (CNTB) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow CNTB on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to CNTB for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.